Zenith® TXD Post-market Surveillance in Japan

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 28, 2023

Study Completion Date

March 28, 2023

Conditions
Aortic Dissection
Interventions
DEVICE

Zenith® TXD

Zenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta

Trial Locations (27)

802-8555

Kokura Memorial Hospital, Fukuoka

812-8582

Kyushu University Hospital, Fukuoka

963-8563

Minami Tohoku Hospital, Fukushima

973-8555

Iwaki Kyoritsu Hospital, Fukushima

041-8680

Hospital Hakodate Hokkaido, Hokkaido

050-0076

Steel Memorial Muroran Hospital, Hokkaido

670-0981

Hyogo Brain and Heart Center, Hyōgo

514-8507

Mie University Hospital, Mie

980-0873

Sendai Kousei Hospital, Miyagi

390-8621

Shinshu University Hospital, Nagoya

632-8552

Tenri Hospital, Nara

903-0215

University of the Ryukyus Hospital, Okinawa

536-0025

Morinomiya Hospital, Osaka

580-0032

Matsubara Tokushukai Hospital, Osaka

589-8511

Kinki University Hospital, Faculty of Medicine, Osaka

879-5593

Oita University Hospital, Ōita

350-1298

Saitama International Medical Center, Saitama

321-0293

Dokkyo Medical Univercity Hospital, Tochigi

321-0974

Saiseikai Utsunomiya Hospital, Tochigi

105-8471

Jikei University School of Medicine, Tokyo

160-0023

Tokyo Medical University Hospital, Tokyo

160-8582

Keio University Hospital, Tokyo

162-8666

Tokyo Women's Medical University Hospital, Tokyo

180-8610

Japanese Red Cross Musashino Hospital, Tokyo

990-2292

Yamagata Prefectural Central Hospital, Yamagata

998-8501

Nihonkai General Hospital, Yamagata

747-8511

Yamaguchi Grand Medical Center, Yamaguchi

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT02663739 - Zenith® TXD Post-market Surveillance in Japan | Biotech Hunter | Biotech Hunter